Published in Virchows Arch on June 07, 2006
Clinicopathological features and prognosis assessment of extranodal follicular dendritic cell sarcoma. World J Gastroenterol (2010) 1.29
Follicular dendritic cell sarcoma of the pharyngeal region. Oncol Lett (2013) 1.02
Extranodal follicular dendritic cell sarcoma in mesentery: A case report. Oncol Lett (2011) 1.01
Clinicopathologic characteristics of inflammatory pseudotumor-like follicular dendritic cell sarcoma. Int J Clin Exp Pathol (2014) 0.99
Imaging findings of follicular dendritic cell sarcoma: report of four cases. Korean J Radiol (2011) 0.96
Podoplanin (d2-40): a new immunohistochemical marker for reactive follicular dendritic cells and follicular dendritic cell sarcomas. Int J Clin Exp Pathol (2008) 0.90
Follicular Dendritic Cell Sarcoma of the Inflammatory Pseudotumor-like Variant Presenting as a Colonic Polyp. Korean J Pathol (2014) 0.89
Extranodal follicular dendritic cell sarcoma: A clinicopathological report of four cases and a literature review. Oncol Lett (2014) 0.88
Follicular dendritic cell sarcoma of the head and neck: Case report, literature review, and pooled analysis of 97 cases. Head Neck (2015) 0.87
Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years. Cancers (Basel) (2014) 0.87
Follicular dendritic cell sarcoma of the neck: report of a case treated by surgical excision and COP plus (PEG)-liposomal doxorubicin. J Exp Clin Cancer Res (2008) 0.84
Primary nasopharyngeal interdigitating dendritic cell tumor presentation and response to radiation therapy. Rare Tumors (2010) 0.83
Follicular dendritic cell sarcoma of the stomach: case report and review of the literature. Curr Oncol (2014) 0.81
Follicular Dendritic Cell Tumor in Liver: A Case Report and Collective Review. Gastroenterology Res (2010) 0.81
Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-κB regulatory genes. Mod Pathol (2015) 0.79
Follicular Dendritic Cell Sarcoma Mediastinum - a case report. Indian J Surg Oncol (2014) 0.79
Dendritic cell sarcomas/tumours of the breast: report of two cases. Virchows Arch (2009) 0.79
Follicular dendritic cell sarcoma: two rare cases and a brief review of the literature. Onco Targets Ther (2015) 0.79
Follicular dendritic cell sarcoma of the tonsil. BMJ Case Rep (2013) 0.78
A 46-year-old Chinese woman presenting with retroperitoneal follicular dendritic cell sarcoma: a case report. J Med Case Rep (2014) 0.78
Follicular dendritic cell sarcoma of the spleen: A case report and review of the literature. Oncol Lett (2016) 0.75
Clinicopathological characteristics of mediastinal follicular dendritic cell sarcoma: report of three cases. J Cardiothorac Surg (2016) 0.75
Splenic inflammatory pseudotumor-like follicular dendritic cell tumor. Case Rep Oncol (2014) 0.75
Primary follicular dendritic cell sarcoma of the urinary bladder: the first case report and potential diagnostic pitfalls. Diagn Pathol (2017) 0.75
Follicular dendritic cell sarcoma of the right tonsil: A case report and literature review. Oncol Lett (2014) 0.75
Extranodal Follicular Dendritic Cell Sarcoma Originating in the Pancreas: A Case Report. Medicine (Baltimore) (2016) 0.75
[Intrahepatic sarcoma of the follicular dendritic cells]. Pathologe (2010) 0.75
Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer (1997) 2.98
A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation. A report of 4 cases. Am J Pathol (1986) 2.81
Inflammatory pseudotumor-like follicular dendritic cell tumor: a distinctive low-grade malignant intra-abdominal neoplasm with consistent Epstein-Barr virus association. Am J Surg Pathol (2001) 2.55
Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. Am J Hematol (1998) 1.85
Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases. Am J Surg Pathol (1997) 1.62
Development of follicular dendritic cell sarcoma in hyaline-vascular Castleman's disease of the nasopharynx: tracing its evolution by sequential biopsies. Histopathology (2001) 1.61
Follicular dendritic cell tumor: report of 13 additional cases of a distinctive entity. Am J Surg Pathol (1996) 1.58
Extranodal follicular dendritic cell sarcoma of the head and neck region: three new cases, with a review of the literature. Mod Pathol (2002) 1.56
Follicular dendritic cell tumor: review of the entity. Semin Diagn Pathol (1998) 1.46
Follicular dendritic cell tumors of the oral cavity. Am J Surg Pathol (1994) 1.39
Follicular dendritic cell tumor of the liver. Evidence for an Epstein-Barr virus-related clonal proliferation of follicular dendritic cells. Am J Surg Pathol (1996) 1.28
Inflammatory pseudotumor of the liver. Evidence for follicular dendritic reticulum cell proliferation associated with clonal Epstein-Barr virus. Am J Surg Pathol (1996) 1.27
Follicular dendritic cell tumor of the liver: a clinicopathologic and Epstein-Barr virus study of two cases. Mod Pathol (2001) 1.26
Inflammatory pseudotumor-like follicular dendritic cell tumor of the spleen. Pathol Int (2004) 1.23
Human follicular dendritic cells: function, origin and development. Semin Immunol (2002) 1.21
Follicular dendritic reticulum cell tumor mimicking inflammatory pseudotumor of the spleen. Pathol Oncol Res (2004) 1.17
Follicular dendritic cell tumor in the oro-pharyngeal region: report of a case and a review of the literature. Oral Oncol (2003) 1.17
So-called inflammatory myofibroblastic tumour: a proliferative lesion of fibroblastic reticulum cells? Histopathology (2005) 1.12
Follicular dendritic cell tumour of the tonsil. Histopathology (1996) 1.10
Extranodal follicular dendritic cell sarcoma of the gastrointestinal tract. Morphologic, immunohistochemical and ultrastructural analysis of two cases. Am J Clin Pathol (1995) 1.05
Hepatic follicular dendritic cell sarcoma without Epstein-Barr virus expression. Arch Pathol Lab Med (2005) 1.04
Extranodal follicular dendritic cell sarcoma of the palate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1999) 1.04
Intra-abdominal follicular dendritic cell tumour: a rare tumour in need of recognition. Histopathology (1998) 1.03
Follicular dendritic cell-derived antigen and accessory activity in initiation of memory IgG responses in vitro. J Immunol (1996) 1.02
Follicular dendritic cell sarcoma of the neck: report of two cases complicated by pulmonary metastases. Cancer (2000) 0.98
Extranodal follicular dendritic cell tumor of the abdominal wall. J Clin Oncol (1999) 0.97
Follicular dendritic cell sarcoma of the colon mimicking stromal tumour. Histopathology (2001) 0.96
Follicular dendritic cell tumor of the parapharyngeal region. Head Neck (1999) 0.96
Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castleman's tumor. J Am Acad Dermatol (1999) 0.93
Dendritic cell sarcoma of the thyroid. Head Neck (1999) 0.90
Follicular dendritic cell tumor: an aggressive head and neck tumor. Am J Otolaryngol (2002) 0.90
A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: strong clusterin immunostaining is highly specific for follicular dendritic cell tumor. Mod Pathol (2005) 0.90
Follicular dendritic cells share a membrane-bound protein with fibroblasts. J Pathol (2000) 0.90
Follicular dendritic cell sarcoma presenting as a submucosal tumor of the stomach. Arch Pathol Lab Med (2000) 0.89
Extranodal follicular dendritic cell tumour of the nasopharynx. Virchows Arch (1998) 0.87
Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman's disease): evidence for dysplasia of follicular dendritic reticulum cells. Histopathology (1991) 0.86
Myxoid variant of follicular dendritic cell sarcoma arising in the breast. Ann Diagn Pathol (1999) 0.83
Follicular dendritic cell sarcoma complicated by hyaline-vascular type Castleman's disease in a schizophrenic patient. Pathol Int (1997) 0.82
Follicular dendritic cell tumor presenting in the lung: a case report. Hum Pathol (2001) 0.82
Metastatic follicular dendritic cell sarcoma of the stomach: a case report and review of the literature. Acta Gastroenterol Belg (2004) 0.81
Retroperitoneal follicular dendritic cell sarcoma presenting as secondary amyloidosis. Surgery (2001) 0.80
Follicular dendritic cell tumour in a 9-year-old child. Pediatr Blood Cancer (2005) 0.78
Isolation of multicellular complexes of follicular dendritic cells and lymphocytes: immunophenotypical characterization, electron microscopy and culture studies. Cell Tissue Res (1989) 0.77
Classic follicular dendritic reticulum cell tumor of the lymph node developing in a patient with a previous inflammatory pseudotumor-like proliferation. Hum Pathol (2005) 0.75
DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (2011) 10.26
Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for Fungi. Proc Natl Acad Sci U S A (2012) 10.22
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol (2005) 8.08
Early appraisal of China's huge and complex health-care reforms. Lancet (2012) 7.71
WormBase: a cross-species database for comparative genomics. Nucleic Acids Res (2003) 5.28
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res (2006) 4.83
An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol (2004) 4.74
BIPES, a cost-effective high-throughput method for assessing microbial diversity. ISME J (2010) 4.52
Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis. Am J Surg Pathol (2005) 3.99
Solid-pseudopapillary tumor of the pancreas: a surgical enigma? Ann Surg Oncol (2002) 3.96
Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents. Cancer Cell (2004) 3.55
SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood (2007) 3.52
Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A (2011) 3.51
Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell (2003) 3.33
Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol (2004) 3.08
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas (2010) 3.00
Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. J Natl Cancer Inst (2010) 2.79
Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch (2005) 2.76
Realignment of incentives for health-care providers in China. Lancet (2010) 2.71
Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg (2002) 2.71
Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol (2003) 2.69
Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem (2008) 2.57
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol (2010) 2.56
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum (2004) 2.52
Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol (2009) 2.50
The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas (2010) 2.43
Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol (2002) 2.39
Objective quantification of the Ki67 proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods. Am J Surg Pathol (2012) 2.38
Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol (2002) 2.35
Post-treatment endoscopic biopsy is a poor-predictor of pathologic response in patients undergoing chemoradiation therapy for esophageal cancer. Ann Surg (2009) 2.32
The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci U S A (2007) 2.31
Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery (2009) 2.29
Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol (2008) 2.27
Planar cell polarity breaks bilateral symmetry by controlling ciliary positioning. Nature (2010) 2.23
Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg (2005) 2.19
Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci U S A (2007) 2.17
Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg (2003) 2.16
Results after pancreatic resection for metastatic lesions. Ann Surg Oncol (2002) 2.15
The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum. Pancreas (2010) 2.13
Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet (2009) 2.12
Clinically aggressive solid pseudopapillary tumors of the pancreas: a report of two cases with components of undifferentiated carcinoma and a comparative clinicopathologic analysis of 34 conventional cases. Am J Surg Pathol (2005) 2.12
The tumor suppressor PP2A Abeta regulates the RalA GTPase. Cell (2007) 2.10
Prospective study of serum 25-hydroxyvitamin D concentration and mortality in a Chinese population. Am J Epidemiol (2012) 2.08
Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg (2003) 2.05
Template for Reporting Results of HER2 (ERBB2) Biomarker Testing of Specimens From Patients With Adenocarcinoma of the Stomach or Esophagogastric Junction. Arch Pathol Lab Med (2014) 2.02
Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res (2011) 2.00
Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol (2002) 1.96
DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7. Cancer Biol Ther (2003) 1.96
Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol (2004) 1.96
Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology (2012) 1.94
cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol (2008) 1.93
Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci U S A (2008) 1.92
Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell (2010) 1.92
Rectus flap reconstruction decreases perineal wound complications after pelvic chemoradiation and surgery: a cohort study. Ann Surg Oncol (2005) 1.92
The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg (2006) 1.90
Structural basis of ultraviolet-B perception by UVR8. Nature (2012) 1.86
Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy. Oncologist (2008) 1.85
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer? Ann Surg Oncol (2007) 1.84
Accuracy of endorectal ultrasonography in preoperative staging of rectal tumors. Dis Colon Rectum (2002) 1.83
Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer (2006) 1.82
Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients. Cancer (2002) 1.82
Stabilization of beta-catenin induces pancreas tumor formation. Gastroenterology (2008) 1.81
Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer (2006) 1.79
Clinical characteristics and outcomes from an institutional series of acinar cell carcinoma of the pancreas and related tumors. J Clin Oncol (2002) 1.78
External and internal constraints on eukaryotic chemotaxis. Proc Natl Acad Sci U S A (2010) 1.78
Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. Ann Surg Oncol (2011) 1.75
Use of surgery among elderly patients with stage IV colorectal cancer. J Clin Oncol (2004) 1.74
Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol (2003) 1.73
Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol (2012) 1.71
The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol (2002) 1.68
Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study. Mod Pathol (2005) 1.67
Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg (2002) 1.66
Management of primary liver sarcomas. Cancer (2007) 1.65
Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg (2002) 1.65
Lymphoepithelial cysts of the pancreas: a report of 12 cases and a review of the literature. Mod Pathol (2002) 1.65
Consensus guidelines for the management and treatment of neuroendocrine tumors. Pancreas (2013) 1.65
Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg (2005) 1.64
Close distal margin and rectal cancer recurrence after sphincter-preserving rectal resection. Dis Colon Rectum (2010) 1.64
Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? J Clin Oncol (2007) 1.64
Combined buccal mucosa graft and local flap for urethral reconstruction in various forms of hyposapdias. J Urol (2005) 1.62
Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection? Ann Surg Oncol (2004) 1.62
Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol (2008) 1.61
Combined classical carcinoid and goblet cell carcinoid tumor: a new morphologic variant of carcinoid tumor of the appendix. Am J Surg Pathol (2010) 1.61
Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol (2006) 1.60